|Articles|June 28, 2016

Nexera-e Comprehensive LCxLC System – Exponential chromatography

Shimadzu has introduced its new Nexera-e comprehensive LCxLC system. The instrument combines two orthogonal separation modes to separate even the most complex mixtures, such as structural analogues in food and natural extracts, in just one analysis. The "e" implies exponentially better chromatography due to an exponential increase in peak capacity and resolution, enabling the analysis of multiple compounds and identification of chemical class patterns in a single chromatogram. One injection and sample preparation instead of several approaches underlines the system's efficiency.


The ultra-fast LCMS-2020 single quadrupole LC-MS detector provides selective, highly sensitive analysis of trace components. The ChromSquare V2 data analysis software for intuitive 2D data processing and visualization completes the package.

 

For more information please visit www.shimadzu.eu

Related to this article

Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.